C. Weyer
Clinical Diabetes and Nutrition Section
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Phoenix
USA
Name/email consistency: high
- Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Weyer, C., Tataranni, P.A., Bogardus, C., Pratley, R.E. Diabetes. Care (2001)
- Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., Tataranni, P.A. J. Clin. Endocrinol. Metab. (2001)
- Changes in energy metabolism in response to 48 h of overfeeding and fasting in Caucasians and Pima Indians. Weyer, C., Vozarova, B., Ravussin, E., Tataranni, P.A. Int. J. Obes. Relat. Metab. Disord. (2001)
- Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. Weyer, C., Pratley, R.E., Salbe, A.D., Bogardus, C., Ravussin, E., Tataranni, P.A. J. Clin. Endocrinol. Metab. (2000)
- Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Weyer, C., Tataranni, P.A., Pratley, R.E. Diabetes. Care (2000)
- Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment. Weyer, C., Walford, R.L., Harper, I.T., Milner, M., MacCallum, T., Tataranni, P.A., Ravussin, E. Am. J. Clin. Nutr. (2000)
- Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Weyer, C., Pratley, R.E., Snitker, S., Spraul, M., Ravussin, E., Tataranni, P.A. Hypertension (2000)
- A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Weyer, C., Hanson, R.L., Tataranni, P.A., Bogardus, C., Pratley, R.E. Diabetes (2000)
- Relationship between birth weight and body composition, energy metabolism, and sympathetic nervous system activity later in life. Weyer, C., Pratley, R.E., Lindsay, R.S., Tataranni, P.A. Obes. Res. (2000)
- Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update. Weyer, C., Gautier, J.F., Danforth, E. Diabetes Metab. (1999)
- Energy metabolism in African Americans: potential risk factors for obesity. Weyer, C., Snitker, S., Bogardus, C., Ravussin, E. Am. J. Clin. Nutr. (1999)
- Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Weyer, C., Bogardus, C., Pratley, R.E. Diabetes (1999)
- Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Weyer, C., Snitker, S., Rising, R., Bogardus, C., Ravussin, E. Int. J. Obes. Relat. Metab. Disord. (1999)
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Weyer, C., Bogardus, C., Mott, D.M., Pratley, R.E. J. Clin. Invest. (1999)
- Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. Weyer, C., Pratley, R.E. Obes. Res. (1999)
- Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Weyer, C., Bogardus, C., Pratley, R.E. Diabetes (1999)
- Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Weyer, C., Tataranni, P.A., Snitker, S., Danforth, E., Ravussin, E. Diabetes (1998)
